Skip to content

Rifaximin EP Impurity D & H

Rifaximin EP Impurity D & H

Product Description
CAT No.
ALN-R027015
CAS No.
NA
Mol. F.
C43H49N3O12 : C43H51N3O12
Mol. Wt.
799.9 : 801.9
Stock
Please Inquire
RFQ
Smiles : CC1=CC2=NC3=C(C(NC(/C(C)=C\C=C\[C@]4(O)C)=O)=C(O)C5=C3C6=C(O[C@](C)(O/C=C\[C@]([H])(OC)C([H])(C)[C@@]([H])(OC(C)=O)[C@]([H])(C)[C@]([H])(O)[C@@](C)([H])C4=O)C6=O)C(C)=C5O)N2C=C1.CC7=CC8=NC9=C(C(N%10)=C(O)C%11=C9C%12=C(O[C@](C)(O/C=C/[C@]([H])(OC)[C@@]([H])(C)[C@@]([H])(OC(C)=O)[C@]([H])(C)[C@]([H])(O)[C@@](C)([H])[C@@]([H])(O)[C@](C)([H])/C=C/C=C(CO)\C%10=O)C%12=O)C(C)=C%11O)N8C=C7
Inchi : InChI=1S/C26H45NO6S/c1-16(4-7-23(30)27-12-13-34(31,32)33)19-5-6-20-24-21(9-11-26(19,20)3)25(2)10-8-18(28)14-17(25)15-22(24)29/h16-22,24,28-29H,4-15H2,1-3H3,(H,27,30)(H,31,32,33)/t16-,17+,18-,19-,20+,21+,22+,24+,25+,26-/m1/s1

Structural elucidation of the Rifaximin Ph. Eur. Impurity H

Riccardo Stradi, Donatella Nava, Marino Nebuloni, Barbara Pastura, ElenaPininJournal of Pharmaceutical and Biomedical Analysis Volume 51, Issue 4, 11 March 2010, Pages 858-865

Structure Elucidation of Two Unknown Oxydic Degradation Impurities of Rifaximin

chao liu, chang-qin hu\xa0 and shao-hong jin – Asian Journal of Chemistry; Vol. 23, No. 7 (2011), 3252-3256

Development and validation of rp-hplc method for the estimation of rifaximin in bulk and in tablet dosage form

T.sudha, P.V.hemalatha, V.R.ravikumar,r.jothi, M.radhakrishnan – Asian Journal of Pharmaceutical and Clinical Research Vol.2 Issue 4, October-December 2009

Request For Quotation

Related Products